CIBC Asset Management
LEGN icon

CIBC Asset Management’s Legend Biotech LEGN Stock Holding History

CIBC Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,630
Closed -$235K – 1264
2025
Q2 		$235K Sell
6,630
-180
-3% -$5.83K ﹤0.01% 1017
2025
Q1 		$231K Buy
6,810
+112
+2% +$4.02K ﹤0.01% 988
2024
Q4 		$218K Buy
6,698
+149
+2% +$6.17K ﹤0.01% 1070
2024
Q3 		$319K Buy
6,549
+170
+3% +$9.05K ﹤0.01% 854
2024
Q2 		$283K Buy
+6,379
New +$294K ﹤0.01% 857

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

CIBC Asset Management's LEGN Position: Q3 2025 in Review

CIBC Asset Management sold out of Legend Biotech (LEGN) in Q3 2025, closing a stake of 6,630 shares — an estimated $235K sold.

CIBC Asset Management first reported a position in LEGN in Q2 2024 and held it in 5 quarters. The position peaked at $319K in Q3 2024. 200 funds tracked by Wall St. Rank hold LEGN as of Q3 2025.

  • CIBC Asset Management reported no remaining Legend Biotech position as of Q3 2025 after selling out during the quarter.
  • CIBC Asset Management sold 6,630 Legend Biotech shares in Q3 2025, an estimated $235K.
  • CIBC Asset Management first reported a position in Legend Biotech in Q2 2024 and held it in 5 quarters.
  • CIBC Asset Management's Legend Biotech position peaked at $319K in Q3 2024.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2025.

Based on CIBC Asset Management's 13F filing for Q3 2025, filed 31 Oct 2025.